Bipolar II disorder: modelling, measuring and managing
The lifetime risk of developing bipolar II disorder is 5-7%, yet the condition is often poorly detected. Mood elevation states are less extreme than in bipolar I disorder although the depressive episodes are usually severe. When correctly treated, the outcome is positive, but bipolar II is often poo...
Gespeichert in:
Weitere Verfasser: | |
---|---|
Format: | Elektronisch E-Book |
Sprache: | English |
Veröffentlicht: |
Cambridge
Cambridge University Press
2012
|
Ausgabe: | Second edition |
Schlagworte: | |
Online-Zugang: | BSB01 FHN01 Volltext |
Zusammenfassung: | The lifetime risk of developing bipolar II disorder is 5-7%, yet the condition is often poorly detected. Mood elevation states are less extreme than in bipolar I disorder although the depressive episodes are usually severe. When correctly treated, the outcome is positive, but bipolar II is often poorly managed, resulting in a high suicide rate. This is the only academic and clinical management review focusing entirely on bipolar II, scrutinizing history, epidemiology, burden and neurobiology and including an extensive clinical debate by international experts about effective management strategies. New chapters cover comorbidity, over-represented personality styles, illness 'trajectories' and distinguishing bipolar II from personality-based emotional dysregulation states. Evidence for different clinical management options is reviewed in detail, two clinical management models are presented and then debated. This book is essential reading for all health professionals managing mood disorders and informative to patients seeking information about their condition and treatment options |
Beschreibung: | Title from publisher's bibliographic system (viewed on 05 Oct 2015) |
Beschreibung: | 1 online resource (xv, 283 pages) |
ISBN: | 9781139003315 |
DOI: | 10.1017/CBO9781139003315 |
Internformat
MARC
LEADER | 00000nmm a2200000zc 4500 | ||
---|---|---|---|
001 | BV043944609 | ||
003 | DE-604 | ||
005 | 00000000000000.0 | ||
007 | cr|uuu---uuuuu | ||
008 | 161206s2012 |||| o||u| ||||||eng d | ||
020 | |a 9781139003315 |c Online |9 978-1-139-00331-5 | ||
024 | 7 | |a 10.1017/CBO9781139003315 |2 doi | |
035 | |a (ZDB-20-CBO)CR9781139003315 | ||
035 | |a (OCoLC)967779570 | ||
035 | |a (DE-599)BVBBV043944609 | ||
040 | |a DE-604 |b ger |e rda | ||
041 | 0 | |a eng | |
049 | |a DE-12 |a DE-92 | ||
082 | 0 | |a 616.85/27 |2 23 | |
245 | 1 | 0 | |a Bipolar II disorder |b modelling, measuring and managing |c edited by Gordon Parker |
250 | |a Second edition | ||
264 | 1 | |a Cambridge |b Cambridge University Press |c 2012 | |
300 | |a 1 online resource (xv, 283 pages) | ||
336 | |b txt |2 rdacontent | ||
337 | |b c |2 rdamedia | ||
338 | |b cr |2 rdacarrier | ||
500 | |a Title from publisher's bibliographic system (viewed on 05 Oct 2015) | ||
505 | 8 | |a Introduction to the second edition -- Bipolar disorder in historical perspective / Edward Shorter -- The bipolar spectrum / James Phelps -- Defining and measuring bipolar II disorder / Gordon Parker -- Bipolar II disorder in context : a review of epidemiology, disability and economic burden / George Hadjipavlou, David J. Bond and Lakshmi N. Yatham -- Comorbid conditions associated with bipolar II disorder / Gordon Parker -- Is bipolar II disorder increasing in prevalence? / Gordon Parker -- Personality styles associated with bipolar II disorder / Kathryn Fletcher -- Distinguishing bipolar II disorder from personality-based states of emotional dysregulation / Joel Paris -- The neurobiology of bipolar II disorder / Emre Bora and Christos Pantellis -- The role of antidepressants in managing bipolar II disorder / Joseph Goldberg -- Current status of mood stabilisers in the management of bipolar II disorder / George Hadjipavlou, David J. Bond and Lakshmi Yatham -- | |
505 | 8 | |a The use of atypical antipsychotic drugs in bipolar II disorder / Eduard Vieta and Nuria Cruz -- The role of fish oil in managing bipolar II disorder / Anne-Marie Rees -- Psychological interventions for bipolar II disorder / Vijaya Manicavasagar and David Gilfillin -- The role of wellbeing plans in managing bipolar II disorder / Margo Orum -- The trajectory of illness experienced by those with bipolar II disorder / Tessa Cleradin -- Clinical models for managing bipolar II disorder : model one / Gordon Parker -- Clinical models for managing bipolar II disorder : model two / Terence Ketter and Po Wang -- Management commentary / Darryl Bassett -- Management commentary / Michael Berk -- Management commentary / Sophia Frangou -- Management commentary / Mark Frye -- Management commentary / S. Nassir Ghaemi -- Management commentary / Michael Gitlin and David Miklowitz -- Management commentary / Joseph Goldberg -- Management commentary / Guy Goodwin -- | |
505 | 8 | |a Management commentary / Andrew Nierenberg -- Management commentary / Robert Post -- Management commentary / Michael Thase -- Management commentary / Eduard Vieta -- Management commentary / Allan Young -- Rounding up and tying down / Gordon Parker | |
520 | |a The lifetime risk of developing bipolar II disorder is 5-7%, yet the condition is often poorly detected. Mood elevation states are less extreme than in bipolar I disorder although the depressive episodes are usually severe. When correctly treated, the outcome is positive, but bipolar II is often poorly managed, resulting in a high suicide rate. This is the only academic and clinical management review focusing entirely on bipolar II, scrutinizing history, epidemiology, burden and neurobiology and including an extensive clinical debate by international experts about effective management strategies. New chapters cover comorbidity, over-represented personality styles, illness 'trajectories' and distinguishing bipolar II from personality-based emotional dysregulation states. Evidence for different clinical management options is reviewed in detail, two clinical management models are presented and then debated. This book is essential reading for all health professionals managing mood disorders and informative to patients seeking information about their condition and treatment options | ||
650 | 4 | |a Manic-depressive illness | |
650 | 4 | |a Manic-depressive illness / Diagnosis | |
650 | 4 | |a Manic-depressive illness / Etiology | |
650 | 4 | |a Manic-depressive illness / Treatment | |
650 | 0 | 7 | |a Diagnose |0 (DE-588)4012040-5 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Manisch-depressive Krankheit |0 (DE-588)4037350-2 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Therapie |0 (DE-588)4059798-2 |2 gnd |9 rswk-swf |
655 | 7 | |8 1\p |0 (DE-588)4143413-4 |a Aufsatzsammlung |2 gnd-content | |
689 | 0 | 0 | |a Manisch-depressive Krankheit |0 (DE-588)4037350-2 |D s |
689 | 0 | 1 | |a Diagnose |0 (DE-588)4012040-5 |D s |
689 | 0 | 2 | |a Therapie |0 (DE-588)4059798-2 |D s |
689 | 0 | |8 2\p |5 DE-604 | |
700 | 1 | |a Parker, Gordon |d 1942- |4 edt | |
776 | 0 | 8 | |i Erscheint auch als |n Druckausgabe |z 978-1-107-60089-8 |
856 | 4 | 0 | |u https://doi.org/10.1017/CBO9781139003315 |x Verlag |z URL des Erstveröffentlichers |3 Volltext |
912 | |a ZDB-20-CBO | ||
999 | |a oai:aleph.bib-bvb.de:BVB01-029353579 | ||
883 | 1 | |8 1\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
883 | 1 | |8 2\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
966 | e | |u https://doi.org/10.1017/CBO9781139003315 |l BSB01 |p ZDB-20-CBO |q BSB_PDA_CBO |x Verlag |3 Volltext | |
966 | e | |u https://doi.org/10.1017/CBO9781139003315 |l FHN01 |p ZDB-20-CBO |q FHN_PDA_CBO |x Verlag |3 Volltext |
Datensatz im Suchindex
_version_ | 1804176889683640320 |
---|---|
any_adam_object | |
author2 | Parker, Gordon 1942- |
author2_role | edt |
author2_variant | g p gp |
author_facet | Parker, Gordon 1942- |
building | Verbundindex |
bvnumber | BV043944609 |
collection | ZDB-20-CBO |
contents | Introduction to the second edition -- Bipolar disorder in historical perspective / Edward Shorter -- The bipolar spectrum / James Phelps -- Defining and measuring bipolar II disorder / Gordon Parker -- Bipolar II disorder in context : a review of epidemiology, disability and economic burden / George Hadjipavlou, David J. Bond and Lakshmi N. Yatham -- Comorbid conditions associated with bipolar II disorder / Gordon Parker -- Is bipolar II disorder increasing in prevalence? / Gordon Parker -- Personality styles associated with bipolar II disorder / Kathryn Fletcher -- Distinguishing bipolar II disorder from personality-based states of emotional dysregulation / Joel Paris -- The neurobiology of bipolar II disorder / Emre Bora and Christos Pantellis -- The role of antidepressants in managing bipolar II disorder / Joseph Goldberg -- Current status of mood stabilisers in the management of bipolar II disorder / George Hadjipavlou, David J. Bond and Lakshmi Yatham -- The use of atypical antipsychotic drugs in bipolar II disorder / Eduard Vieta and Nuria Cruz -- The role of fish oil in managing bipolar II disorder / Anne-Marie Rees -- Psychological interventions for bipolar II disorder / Vijaya Manicavasagar and David Gilfillin -- The role of wellbeing plans in managing bipolar II disorder / Margo Orum -- The trajectory of illness experienced by those with bipolar II disorder / Tessa Cleradin -- Clinical models for managing bipolar II disorder : model one / Gordon Parker -- Clinical models for managing bipolar II disorder : model two / Terence Ketter and Po Wang -- Management commentary / Darryl Bassett -- Management commentary / Michael Berk -- Management commentary / Sophia Frangou -- Management commentary / Mark Frye -- Management commentary / S. Nassir Ghaemi -- Management commentary / Michael Gitlin and David Miklowitz -- Management commentary / Joseph Goldberg -- Management commentary / Guy Goodwin -- Management commentary / Andrew Nierenberg -- Management commentary / Robert Post -- Management commentary / Michael Thase -- Management commentary / Eduard Vieta -- Management commentary / Allan Young -- Rounding up and tying down / Gordon Parker |
ctrlnum | (ZDB-20-CBO)CR9781139003315 (OCoLC)967779570 (DE-599)BVBBV043944609 |
dewey-full | 616.85/27 |
dewey-hundreds | 600 - Technology (Applied sciences) |
dewey-ones | 616 - Diseases |
dewey-raw | 616.85/27 |
dewey-search | 616.85/27 |
dewey-sort | 3616.85 227 |
dewey-tens | 610 - Medicine and health |
discipline | Medizin |
doi_str_mv | 10.1017/CBO9781139003315 |
edition | Second edition |
format | Electronic eBook |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>05597nmm a2200589zc 4500</leader><controlfield tag="001">BV043944609</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">161206s2012 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781139003315</subfield><subfield code="c">Online</subfield><subfield code="9">978-1-139-00331-5</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1017/CBO9781139003315</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-20-CBO)CR9781139003315</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)967779570</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV043944609</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-12</subfield><subfield code="a">DE-92</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.85/27</subfield><subfield code="2">23</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Bipolar II disorder</subfield><subfield code="b">modelling, measuring and managing</subfield><subfield code="c">edited by Gordon Parker</subfield></datafield><datafield tag="250" ind1=" " ind2=" "><subfield code="a">Second edition</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Cambridge</subfield><subfield code="b">Cambridge University Press</subfield><subfield code="c">2012</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (xv, 283 pages)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Title from publisher's bibliographic system (viewed on 05 Oct 2015)</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">Introduction to the second edition -- Bipolar disorder in historical perspective / Edward Shorter -- The bipolar spectrum / James Phelps -- Defining and measuring bipolar II disorder / Gordon Parker -- Bipolar II disorder in context : a review of epidemiology, disability and economic burden / George Hadjipavlou, David J. Bond and Lakshmi N. Yatham -- Comorbid conditions associated with bipolar II disorder / Gordon Parker -- Is bipolar II disorder increasing in prevalence? / Gordon Parker -- Personality styles associated with bipolar II disorder / Kathryn Fletcher -- Distinguishing bipolar II disorder from personality-based states of emotional dysregulation / Joel Paris -- The neurobiology of bipolar II disorder / Emre Bora and Christos Pantellis -- The role of antidepressants in managing bipolar II disorder / Joseph Goldberg -- Current status of mood stabilisers in the management of bipolar II disorder / George Hadjipavlou, David J. Bond and Lakshmi Yatham -- </subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">The use of atypical antipsychotic drugs in bipolar II disorder / Eduard Vieta and Nuria Cruz -- The role of fish oil in managing bipolar II disorder / Anne-Marie Rees -- Psychological interventions for bipolar II disorder / Vijaya Manicavasagar and David Gilfillin -- The role of wellbeing plans in managing bipolar II disorder / Margo Orum -- The trajectory of illness experienced by those with bipolar II disorder / Tessa Cleradin -- Clinical models for managing bipolar II disorder : model one / Gordon Parker -- Clinical models for managing bipolar II disorder : model two / Terence Ketter and Po Wang -- Management commentary / Darryl Bassett -- Management commentary / Michael Berk -- Management commentary / Sophia Frangou -- Management commentary / Mark Frye -- Management commentary / S. Nassir Ghaemi -- Management commentary / Michael Gitlin and David Miklowitz -- Management commentary / Joseph Goldberg -- Management commentary / Guy Goodwin -- </subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">Management commentary / Andrew Nierenberg -- Management commentary / Robert Post -- Management commentary / Michael Thase -- Management commentary / Eduard Vieta -- Management commentary / Allan Young -- Rounding up and tying down / Gordon Parker</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">The lifetime risk of developing bipolar II disorder is 5-7%, yet the condition is often poorly detected. Mood elevation states are less extreme than in bipolar I disorder although the depressive episodes are usually severe. When correctly treated, the outcome is positive, but bipolar II is often poorly managed, resulting in a high suicide rate. This is the only academic and clinical management review focusing entirely on bipolar II, scrutinizing history, epidemiology, burden and neurobiology and including an extensive clinical debate by international experts about effective management strategies. New chapters cover comorbidity, over-represented personality styles, illness 'trajectories' and distinguishing bipolar II from personality-based emotional dysregulation states. Evidence for different clinical management options is reviewed in detail, two clinical management models are presented and then debated. This book is essential reading for all health professionals managing mood disorders and informative to patients seeking information about their condition and treatment options</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Manic-depressive illness</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Manic-depressive illness / Diagnosis</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Manic-depressive illness / Etiology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Manic-depressive illness / Treatment</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Diagnose</subfield><subfield code="0">(DE-588)4012040-5</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Manisch-depressive Krankheit</subfield><subfield code="0">(DE-588)4037350-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Therapie</subfield><subfield code="0">(DE-588)4059798-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="8">1\p</subfield><subfield code="0">(DE-588)4143413-4</subfield><subfield code="a">Aufsatzsammlung</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Manisch-depressive Krankheit</subfield><subfield code="0">(DE-588)4037350-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Diagnose</subfield><subfield code="0">(DE-588)4012040-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="2"><subfield code="a">Therapie</subfield><subfield code="0">(DE-588)4059798-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="8">2\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Parker, Gordon</subfield><subfield code="d">1942-</subfield><subfield code="4">edt</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druckausgabe</subfield><subfield code="z">978-1-107-60089-8</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1017/CBO9781139003315</subfield><subfield code="x">Verlag</subfield><subfield code="z">URL des Erstveröffentlichers</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-20-CBO</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-029353579</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">1\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">2\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1017/CBO9781139003315</subfield><subfield code="l">BSB01</subfield><subfield code="p">ZDB-20-CBO</subfield><subfield code="q">BSB_PDA_CBO</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1017/CBO9781139003315</subfield><subfield code="l">FHN01</subfield><subfield code="p">ZDB-20-CBO</subfield><subfield code="q">FHN_PDA_CBO</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
genre | 1\p (DE-588)4143413-4 Aufsatzsammlung gnd-content |
genre_facet | Aufsatzsammlung |
id | DE-604.BV043944609 |
illustrated | Not Illustrated |
indexdate | 2024-07-10T07:39:21Z |
institution | BVB |
isbn | 9781139003315 |
language | English |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-029353579 |
oclc_num | 967779570 |
open_access_boolean | |
owner | DE-12 DE-92 |
owner_facet | DE-12 DE-92 |
physical | 1 online resource (xv, 283 pages) |
psigel | ZDB-20-CBO ZDB-20-CBO BSB_PDA_CBO ZDB-20-CBO FHN_PDA_CBO |
publishDate | 2012 |
publishDateSearch | 2012 |
publishDateSort | 2012 |
publisher | Cambridge University Press |
record_format | marc |
spelling | Bipolar II disorder modelling, measuring and managing edited by Gordon Parker Second edition Cambridge Cambridge University Press 2012 1 online resource (xv, 283 pages) txt rdacontent c rdamedia cr rdacarrier Title from publisher's bibliographic system (viewed on 05 Oct 2015) Introduction to the second edition -- Bipolar disorder in historical perspective / Edward Shorter -- The bipolar spectrum / James Phelps -- Defining and measuring bipolar II disorder / Gordon Parker -- Bipolar II disorder in context : a review of epidemiology, disability and economic burden / George Hadjipavlou, David J. Bond and Lakshmi N. Yatham -- Comorbid conditions associated with bipolar II disorder / Gordon Parker -- Is bipolar II disorder increasing in prevalence? / Gordon Parker -- Personality styles associated with bipolar II disorder / Kathryn Fletcher -- Distinguishing bipolar II disorder from personality-based states of emotional dysregulation / Joel Paris -- The neurobiology of bipolar II disorder / Emre Bora and Christos Pantellis -- The role of antidepressants in managing bipolar II disorder / Joseph Goldberg -- Current status of mood stabilisers in the management of bipolar II disorder / George Hadjipavlou, David J. Bond and Lakshmi Yatham -- The use of atypical antipsychotic drugs in bipolar II disorder / Eduard Vieta and Nuria Cruz -- The role of fish oil in managing bipolar II disorder / Anne-Marie Rees -- Psychological interventions for bipolar II disorder / Vijaya Manicavasagar and David Gilfillin -- The role of wellbeing plans in managing bipolar II disorder / Margo Orum -- The trajectory of illness experienced by those with bipolar II disorder / Tessa Cleradin -- Clinical models for managing bipolar II disorder : model one / Gordon Parker -- Clinical models for managing bipolar II disorder : model two / Terence Ketter and Po Wang -- Management commentary / Darryl Bassett -- Management commentary / Michael Berk -- Management commentary / Sophia Frangou -- Management commentary / Mark Frye -- Management commentary / S. Nassir Ghaemi -- Management commentary / Michael Gitlin and David Miklowitz -- Management commentary / Joseph Goldberg -- Management commentary / Guy Goodwin -- Management commentary / Andrew Nierenberg -- Management commentary / Robert Post -- Management commentary / Michael Thase -- Management commentary / Eduard Vieta -- Management commentary / Allan Young -- Rounding up and tying down / Gordon Parker The lifetime risk of developing bipolar II disorder is 5-7%, yet the condition is often poorly detected. Mood elevation states are less extreme than in bipolar I disorder although the depressive episodes are usually severe. When correctly treated, the outcome is positive, but bipolar II is often poorly managed, resulting in a high suicide rate. This is the only academic and clinical management review focusing entirely on bipolar II, scrutinizing history, epidemiology, burden and neurobiology and including an extensive clinical debate by international experts about effective management strategies. New chapters cover comorbidity, over-represented personality styles, illness 'trajectories' and distinguishing bipolar II from personality-based emotional dysregulation states. Evidence for different clinical management options is reviewed in detail, two clinical management models are presented and then debated. This book is essential reading for all health professionals managing mood disorders and informative to patients seeking information about their condition and treatment options Manic-depressive illness Manic-depressive illness / Diagnosis Manic-depressive illness / Etiology Manic-depressive illness / Treatment Diagnose (DE-588)4012040-5 gnd rswk-swf Manisch-depressive Krankheit (DE-588)4037350-2 gnd rswk-swf Therapie (DE-588)4059798-2 gnd rswk-swf 1\p (DE-588)4143413-4 Aufsatzsammlung gnd-content Manisch-depressive Krankheit (DE-588)4037350-2 s Diagnose (DE-588)4012040-5 s Therapie (DE-588)4059798-2 s 2\p DE-604 Parker, Gordon 1942- edt Erscheint auch als Druckausgabe 978-1-107-60089-8 https://doi.org/10.1017/CBO9781139003315 Verlag URL des Erstveröffentlichers Volltext 1\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk 2\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk |
spellingShingle | Bipolar II disorder modelling, measuring and managing Introduction to the second edition -- Bipolar disorder in historical perspective / Edward Shorter -- The bipolar spectrum / James Phelps -- Defining and measuring bipolar II disorder / Gordon Parker -- Bipolar II disorder in context : a review of epidemiology, disability and economic burden / George Hadjipavlou, David J. Bond and Lakshmi N. Yatham -- Comorbid conditions associated with bipolar II disorder / Gordon Parker -- Is bipolar II disorder increasing in prevalence? / Gordon Parker -- Personality styles associated with bipolar II disorder / Kathryn Fletcher -- Distinguishing bipolar II disorder from personality-based states of emotional dysregulation / Joel Paris -- The neurobiology of bipolar II disorder / Emre Bora and Christos Pantellis -- The role of antidepressants in managing bipolar II disorder / Joseph Goldberg -- Current status of mood stabilisers in the management of bipolar II disorder / George Hadjipavlou, David J. Bond and Lakshmi Yatham -- The use of atypical antipsychotic drugs in bipolar II disorder / Eduard Vieta and Nuria Cruz -- The role of fish oil in managing bipolar II disorder / Anne-Marie Rees -- Psychological interventions for bipolar II disorder / Vijaya Manicavasagar and David Gilfillin -- The role of wellbeing plans in managing bipolar II disorder / Margo Orum -- The trajectory of illness experienced by those with bipolar II disorder / Tessa Cleradin -- Clinical models for managing bipolar II disorder : model one / Gordon Parker -- Clinical models for managing bipolar II disorder : model two / Terence Ketter and Po Wang -- Management commentary / Darryl Bassett -- Management commentary / Michael Berk -- Management commentary / Sophia Frangou -- Management commentary / Mark Frye -- Management commentary / S. Nassir Ghaemi -- Management commentary / Michael Gitlin and David Miklowitz -- Management commentary / Joseph Goldberg -- Management commentary / Guy Goodwin -- Management commentary / Andrew Nierenberg -- Management commentary / Robert Post -- Management commentary / Michael Thase -- Management commentary / Eduard Vieta -- Management commentary / Allan Young -- Rounding up and tying down / Gordon Parker Manic-depressive illness Manic-depressive illness / Diagnosis Manic-depressive illness / Etiology Manic-depressive illness / Treatment Diagnose (DE-588)4012040-5 gnd Manisch-depressive Krankheit (DE-588)4037350-2 gnd Therapie (DE-588)4059798-2 gnd |
subject_GND | (DE-588)4012040-5 (DE-588)4037350-2 (DE-588)4059798-2 (DE-588)4143413-4 |
title | Bipolar II disorder modelling, measuring and managing |
title_auth | Bipolar II disorder modelling, measuring and managing |
title_exact_search | Bipolar II disorder modelling, measuring and managing |
title_full | Bipolar II disorder modelling, measuring and managing edited by Gordon Parker |
title_fullStr | Bipolar II disorder modelling, measuring and managing edited by Gordon Parker |
title_full_unstemmed | Bipolar II disorder modelling, measuring and managing edited by Gordon Parker |
title_short | Bipolar II disorder |
title_sort | bipolar ii disorder modelling measuring and managing |
title_sub | modelling, measuring and managing |
topic | Manic-depressive illness Manic-depressive illness / Diagnosis Manic-depressive illness / Etiology Manic-depressive illness / Treatment Diagnose (DE-588)4012040-5 gnd Manisch-depressive Krankheit (DE-588)4037350-2 gnd Therapie (DE-588)4059798-2 gnd |
topic_facet | Manic-depressive illness Manic-depressive illness / Diagnosis Manic-depressive illness / Etiology Manic-depressive illness / Treatment Diagnose Manisch-depressive Krankheit Therapie Aufsatzsammlung |
url | https://doi.org/10.1017/CBO9781139003315 |
work_keys_str_mv | AT parkergordon bipolariidisordermodellingmeasuringandmanaging |